Involvement of the xenobiotic response element (XRE) in ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1

被引:144
|
作者
Yueh, MF
Huang, YH
Hiller, A
Chen, SJ
Nguyen, N
Tukey, RH [1 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Lab Environm Toxicol, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M300645200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UDP-glucuronosyltransferase 1A1 (UGT1A1) plays an important physiological role by contributing to the metabolism of endogenous substances such as bilirubin in addition to xenobiotics and drugs. The UGT1A1 gene has been shown to be inducible by nuclear receptors steroid xenobiotic receptor (SXR) and the constitutive active receptor, CAR. In this report, we show that in human hepatoma HepG2 cells the UGT1A1 gene is also inducible with aryl hydrocarbon receptor (Ah receptor) ligands such as 2,3,7,8-tetrachlodibenzo-p-dioxin (TCDD), beta-naphthoflavone, and benzo[a]pyrene metabolites. Induction was monitored by increases in protein and catalytic activity as well as UGT1A1 mRNA. To examine the molecular interactions that control UGT1A1 expression, the gene was characterized and induction by Ah receptor ligands was regionalized to bases -3338 to -3287. Nucleotide sequence analysis of this UGT1A1 enhancer region revealed a xenobiotic response element (XRE) at -3381/-3299. The dependence of the XRE on UGT1A1-luciferase activity was demonstrated by a loss of Ah receptor ligand inducibility when the XRE core region (CACGCA) was deleted or mutated. Gel mobility shift analysis confirmed that TCDD induction of nuclear proteins specifically bound to the UGT1A1-XRE, and competition experiments with Ah receptor and Arnt antibodies demonstrated that the nuclear protein was the Ah receptor. These observations reveal that the Ah receptor is involved in human UGT1A1 induction.
引用
收藏
页码:15001 / 15006
页数:6
相关论文
共 50 条
  • [21] Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1
    Watanabe, Y
    Nakajima, M
    Ohashi, N
    Kume, T
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 589 - 595
  • [22] Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity
    Hirashima, Rika
    Michimae, Hirofumi
    Takemoto, Hiroaki
    Sasaki, Aya
    Kobayashi, Yoshinori
    Itoh, Tomoo
    Tukey, Robert H.
    Fujiwara, Ryoichi
    MOLECULAR PHARMACOLOGY, 2016, 90 (03) : 265 - 274
  • [23] Function, Genetic Polymorphism, and Transcriptional Regulation of Human UDP-glucuronosyltransferase (UGT) 1A1
    Sugatani, Junko
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 83 - 92
  • [24] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Xuewei Cheng
    Xia Lv
    Hengyan Qu
    Dandan Li
    Mengmeng Hu
    Wenzhi Guo
    Guangbo Ge
    Ruihua Dong
    Acta Pharmaceutica Sinica B, 2017, 7 (06) : 657 - 664
  • [25] Importance of UDP-Glucuronosyltransferase 1A1 Expression in Skin and Its Induction by UVB in Neonatal Hyperbilirubinemias
    Sumida, Kyohei
    Kawana, Makiko
    Kouno, Emi
    Itoh, Tomoo
    Takano, Shuhei
    Narawa, Tomoya
    Tukey, Robert H.
    Fujiwara, Ryoichi
    MOLECULAR PHARMACOLOGY, 2013, 84 (05) : 679 - 686
  • [26] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Cheng, Xuewei
    Lv, Xia
    Qu, Hengyan
    Li, Dandan
    Hu, Mengmeng
    Guo, Wenzhi
    Ge, Guangbo
    Dong, Ruihua
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (06) : 657 - 664
  • [27] UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin
    Fujiwara, Ryoichi
    Sumida, Kyohei
    Kutsuno, Yuki
    Sakamoto, Masaya
    Itoh, Tomoo
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (01) : 82 - 88
  • [28] Ligand orientation governs conjugation capacity of UDP-glucuronosyltransferase 1A1
    Takaoka, Yutaka
    Ohta, Mika
    Takeuchi, Atsuko
    Miura, Kenji
    Matsuo, Masafumi
    Sakaeda, Toshiyuki
    Sugano, Aki
    Nishio, Hisahide
    JOURNAL OF BIOCHEMISTRY, 2010, 148 (01): : 25 - 28
  • [29] Intestinal UDP-Glucuronosyltransferase 1A1 and Protection against Irinotecan-Induced Toxicity in a Novel UDP-Glucuronosyltransferase 1A1 Tissue-Specific Humanized Mouse Model
    Mennillo, Elvira
    Yang, Xiaojing
    Weber, Andre A.
    Maruo, Yoshihiro
    Verreault, Melanie
    Barbier, Olivier
    Chen, Shujuan
    Tukey, Robert H.
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (01) : 33 - 42
  • [30] The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics (vol 67, pg 989, 2004)
    Sugatani, J
    Yamakawa, K
    Tonda, E
    Nishitani, S
    Yoshinari, K
    Degawa, M
    Abe, I
    Noguchi, H
    Miwa, M
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (12) : 2291 - 2292